These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17617379)

  • 1. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
    Chvyrkova I; Zhang XC; Terzyan S
    Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-association of the transmembrane domain of an anthrax toxin receptor.
    Go MY; Kim S; Partridge AW; Melnyk RA; Rath A; Deber CM; Mogridge J
    J Mol Biol; 2006 Jun; 360(1):145-56. PubMed ID: 16756998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism.
    Kintzer AF; Sterling HJ; Tang II; Williams ER; Krantz BA
    PLoS One; 2010 Nov; 5(11):e13888. PubMed ID: 21079738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax toxin complexes: heptameric protective antigen can bind lethal factor and edema factor simultaneously.
    Pimental RA; Christensen KA; Krantz BA; Collier RJ
    Biochem Biophys Res Commun; 2004 Sep; 322(1):258-62. PubMed ID: 15313199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of a complex between anthrax toxin and its host cell receptor.
    Santelli E; Bankston LA; Leppla SH; Liddington RC
    Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.
    Mogridge J; Cunningham K; Lacy DB; Mourez M; Collier RJ
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7045-8. PubMed ID: 11997437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen.
    Cunningham K; Lacy DB; Mogridge J; Collier RJ
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7049-53. PubMed ID: 11997439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells.
    Singh Y; Klimpel KR; Goel S; Swain PK; Leppla SH
    Infect Immun; 1999 Apr; 67(4):1853-9. PubMed ID: 10085027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of N-terminal fragments of anthrax edema factor (EF(N)) and lethal factor (LF(N)) to the protective antigen pore.
    Leuber M; Kronhardt A; Tonello F; Dal Molin F; Benz R
    Biochim Biophys Acta; 2008 Jun; 1778(6):1436-43. PubMed ID: 18243126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion selectivity of the anthrax toxin channel and its effect on protein translocation.
    Schiffmiller A; Anderson D; Finkelstein A
    J Gen Physiol; 2015 Aug; 146(2):183-92. PubMed ID: 26170174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthrax toxin.
    Bhatnagar R; Batra S
    Crit Rev Microbiol; 2001; 27(3):167-200. PubMed ID: 11596878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
    Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.
    Gupta P; Singh A; Chauhan V; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Jan; 280(1):158-63. PubMed ID: 11162493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New aspects of the infection mechanisms of Bacillus anthracis.
    Zakowska D; Bartoszcze M; Niemcewicz M; Bielawska-Drózd A; Kocik J
    Ann Agric Environ Med; 2012; 19(4):613-8. PubMed ID: 23311776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactivity of anthrax and C2 toxin: protective antigen promotes the uptake of botulinum C2I toxin into human endothelial cells.
    Kronhardt A; Rolando M; Beitzinger C; Stefani C; Leuber M; Flatau G; Popoff MR; Benz R; Lemichez E
    PLoS One; 2011; 6(8):e23133. PubMed ID: 21850257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.